Nev. Admin. Code § 453.110

Current through November 25, 2024

Section 453.110 - Groups of activities involving controlled substances: Independent activities requiring separate registration; substances included in registration

1. For the purpose of registration under this chapter, the following groups of activities are deemed to be independent of each other:

(a) Manufacturing any controlled substance;

(b) Distributing any controlled substance;

(c) Dispensing, prescribing, conducting research, except for the research described in paragraph (d), and conducting instructional activities with any controlled substance listed in schedules II through V, inclusive;

(d) Conducting research with any narcotic drug listed in schedules II to V, inclusive, for the purpose of continuing the dependence of a person on the drug in the course of conducting an authorized clinical investigation in the development of a program for rehabilitation of narcotic addicts pursuant to a Notice of Claimed Investigational Exemption for a New Drug approved by the Food and Drug Administration;

(e) Conducting research and instructional activities with any controlled substances listed in schedule I;

(f) Conducting chemical analysis with a controlled substance listed in any schedule; and

(g) Possessing any controlled substance in the course of training canines to detect a controlled substance, by a law enforcement officer who is registered pursuant to section 1.

2. A person who engages in more than one group of independent activities must obtain a separate registration for each group of activities except as provided in NAC 453.120.

3. Except as provided in subsection 4, a single registration to engage in any group of independent activities may include one or more of the controlled substances listed in the schedules which are authorized for that group.

4. A person registered to conduct research with the controlled substances listed in schedule I may conduct research with any substance listed in schedule I for which he or she has filed and had approved a research protocol.

Nev. Admin. Code § 453.110

Bd. of Pharmacy, §453.030, eff. 6-26-80; A by R050-22A, eff. 9/16/2022

NRS 453.221, 453.226, 639.070